Streetbeat News

Price Targets

FCUUF

HC Wainwright & Co. analyst Heiko Ihle maintains a Buy rating on Fission Uranium (OTC:FCUUF) and raises the price target from $1.7 to $1.9.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:20 am

EMX

HC Wainwright & Co. analyst Heiko Ihle maintains a Buy rating on EMX Royalty (AMEX:EMX) with a maintained price target of $6.5.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:18 am

ADBE

Piper Sandler analyst Brent Bracelin has maintained an Overweight rating on Adobe (NASDAQ:ADBE) and kept the price target at $700. This reaffirms the firm's positive outlook on Adobe's stock.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:16 am

NCNO

Piper Sandler analyst Brent Bracelin has maintained an Overweight rating on Ncino (NASDAQ:NCNO) and kept the price target at $42.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:13 am

WPRT

HC Wainwright & Co. analyst Amit Dayal has reaffirmed a Buy rating on Westport Fuel Systems (NASDAQ:WPRT), with a maintained price target of $30. This endorsement could influence investor sentiment and potentially impact WPRT's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:13 am

TGT

Tigress Financial analyst Ivan Feinseth maintains a Buy rating on Target Corporation (TGT) and raises the price target from $180 to $210.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:54 am

LUCD

Needham analyst Mike Matson reiterated a Buy rating on Lucid Diagnostics (NASDAQ:LUCD) and maintained a $2.5 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:20 am

CSGS

RBC Capital analyst Dan Bergstrom initiates coverage on CSG Systems Intl (NASDAQ:CSGS) with an Outperform rating and a price target of $61.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:07 am

V

Redburn Atlantic analyst Fahed Kunwar downgrades Visa (NYSE:V) from Buy to Neutral and sets a $307 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:05 am

THC

Wolfe Research analyst Justin Lake has upgraded Tenet Healthcare (NYSE:THC) from Peer Perform to Outperform, setting a new price target of $122.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:58 am